257 related articles for article (PubMed ID: 35668416)
1. OCT biomarkers related to subthreshold micropulse laser treatment effect in central serous chorioretinopathy.
Zheng F; He J; Su Z; Liu Y; Xu Y; Liu L; Ye P
BMC Ophthalmol; 2022 Jun; 22(1):252. PubMed ID: 35668416
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal injections with anti-VEGF agent aflibercept versus subthreshold micropulse laser for chronic central serous chorioretinopathy: the alternative treatment regimens for verteporfin-shortage in China.
Zhao T; Li J; Wang Y; Guo X; Sun Y
Ann Med; 2023 Dec; 55(1):2227424. PubMed ID: 37382371
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of subthreshold micropulse laser for chronic central serous chorioretinopathy: A meta-analysis.
Li X; Long H; Hu Q
Photodiagnosis Photodyn Ther; 2022 Sep; 39():102931. PubMed ID: 35636735
[TBL] [Abstract][Full Text] [Related]
4. 577 nm subthreshold micropulse laser treatment for acute central serous chorioretinopathy: a comparative study.
Long H; Liu M; Hu Q; Li X
BMC Ophthalmol; 2022 Mar; 22(1):105. PubMed ID: 35248003
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Subthreshold Micropulse Laser for Central Serous Chorioretinopathy.
Fasler K; Turgut F; Gunzinger JM; Sommer C; Muth DR; Kinzl S; Nilius H; Zweifel S; Somfai GM
Klin Monbl Augenheilkd; 2024 Apr; 241(4):489-495. PubMed ID: 38653299
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy and safety between subthreshold micropulse laser, standard-fluence and low-fluence photodynamic therapy for chronic central serous chorioretinopathy.
Altinel MG; Kanra AY; Totuk OMG; Ardagil A; Turkmen OF
J Fr Ophtalmol; 2021 Apr; 44(4):499-508. PubMed ID: 33642060
[TBL] [Abstract][Full Text] [Related]
7. Morphological parameters predicting subthreshold micropulse laser effectiveness in central serous chorioretinopathy.
Kiraly P; Smrekar J; Jaki Mekjavić P
Lasers Med Sci; 2022 Oct; 37(8):3129-3136. PubMed ID: 35579726
[TBL] [Abstract][Full Text] [Related]
8. Crossover to PDT after the unsuccessful micropulse laser treatment of central serous chorioretinopathy.
Gawęcki M; Kiciński K; Grzybowski A
Adv Ophthalmol Pract Res; 2024; 4(1):32-38. PubMed ID: 38406665
[TBL] [Abstract][Full Text] [Related]
9. Influence of Retinal Microsecond Pulse Laser Treatment in Central Serous Chorioretinopathy: A Short-Term Optical Coherence Tomography Angiography Study.
Prasuhn M; Miura Y; Tura A; Rommel F; Kakkassery V; Sonntag S; Grisanti S; Ranjbar M
J Clin Med; 2021 May; 10(11):. PubMed ID: 34072472
[TBL] [Abstract][Full Text] [Related]
10. Central Serous Chorioretinopathy: Morphological and Functional Outcome after Subthreshold Thermal Laser Coagulation with a Frequency-Doubled Nd:YAG Continuous-Wave Laser.
Enders C; Lang GE; Mayer B; Werner JU
Ophthalmologica; 2022; 245(1):59-68. PubMed ID: 34517369
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Navigated Laser Photocoagulation for Chronic Central Serous Chorioretinopathy: A Retrospective Observational Study.
Zhou F; Yao J; Jiang Q; Yang W
Dis Markers; 2022; 2022():7792291. PubMed ID: 35465265
[No Abstract] [Full Text] [Related]
12. Short-term comparison between navigated subthreshold microsecond pulse laser and oral eplerenone for chronic central serous chorioretinopathy.
Toto L; D'Aloisio R; De Nicola C; Evangelista F; Ruggeri ML; Cerino L; Simonelli MB; Aharrh-Gnama A; Di Nicola M; Porreca A; Mastropasqua R
Sci Rep; 2022 Mar; 12(1):4727. PubMed ID: 35304566
[TBL] [Abstract][Full Text] [Related]
13. Optical coherence tomography parameters as predictors of treatment response to a 577-nm subthreshold micropulse laser in chronic central serous chorioretinopathy.
Altınel MG; Acikalin B; Gunes H; Demir G
Lasers Med Sci; 2021 Sep; 36(7):1505-1514. PubMed ID: 33409750
[TBL] [Abstract][Full Text] [Related]
14. Central serous chorioretinopathy imaging biomarkers.
Singh SR; Iovino C; Zur D; Masarwa D; Iglicki M; Gujar R; Lupidi M; Maltsev DS; Bousquet E; Bencheqroun M; Amoroso F; Lima LH; Padhy SK; Govindahari V; Chandra K; Souied EH; Rodriguez FJ; Daza LA; Rios HA; Cagini C; Peiretti E; Behar-Cohen F; Chhablani J
Br J Ophthalmol; 2022 Apr; 106(4):553-558. PubMed ID: 33288526
[TBL] [Abstract][Full Text] [Related]
15. Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy.
Scholz P; Altay L; Fauser S
Eye (Lond); 2016 Oct; 30(10):1371-1377. PubMed ID: 27391938
[TBL] [Abstract][Full Text] [Related]
16. Subthreshold laser compared to oral spironolactone for the treatment of chronic central serous chorioretinopathy: a retrospective study.
Mercuri S; D'Alterio FM; Gallo B; Raslan W; Gupta A; Khairat N; Corazza P; Younis S
Int Ophthalmol; 2024 Mar; 44(1):131. PubMed ID: 38478131
[TBL] [Abstract][Full Text] [Related]
17. Does Subretinal Fluid Optical Density Ratio Differ Among the Eyes with Acute Central Serous Chorioretinopathy,Vogt Koyanagi Harada Disease and Choroidal Hemangioma: A Cross-sectional Study.
Durmaz Engin C; Kayabasi M; Koksaldi S; Ipek SC; Saatci AO
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103634. PubMed ID: 37244453
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of subthreshold micropulse laser in the treatment of acute central serous chorioretinopathy.
Guo JJ; Li XJ; Wan JJ
Int J Ophthalmol; 2023; 16(6):921-927. PubMed ID: 37332544
[TBL] [Abstract][Full Text] [Related]
19. Retro-mode Imaging for retinal pigment epithelium alterations in central serous chorioretinopathy.
Shin YU; Lee BR
Am J Ophthalmol; 2012 Jul; 154(1):155-163.e4. PubMed ID: 22503695
[TBL] [Abstract][Full Text] [Related]
20. En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.
Ferrara D; Mohler KJ; Waheed N; Adhi M; Liu JJ; Grulkowski I; Kraus MF; Baumal C; Hornegger J; Fujimoto JG; Duker JS
Ophthalmology; 2014 Mar; 121(3):719-26. PubMed ID: 24289918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
